Sutro Biopharma STRO Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Sutro Biopharma in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sutro Biopharma's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sutro Biopharma's other non-current liabilities?
- Sutro Biopharma (STRO) reported other non-current liabilities of $1.69M in Q1 2026.
- How has Sutro Biopharma's other non-current liabilities changed year-over-year?
- Sutro Biopharma's other non-current liabilities decreased by 0.0% year-over-year, from $1.69M to $1.69M.
- What is the long-term trend for Sutro Biopharma's other non-current liabilities?
- Over 5 years (2020 to 2025), Sutro Biopharma's other non-current liabilities has grown at a 28.6% compound annual growth rate (CAGR), from $481K to $1.69M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.